Skip Navigation

Europace 2000 2(4):320-326; doi:10.1053/eupc.2000.0123
© 2000 by European Society of Cardiology
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Christiansen, E. H.
Right arrow Articles by Pedersen, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christiansen, E. H.
Right arrow Articles by Pedersen, A. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

ELECTROPHYSIOLOGY

Dose-related cardiac electrophysiological effects of intravenous magnesium. A double-blind placebo-controlled dose-response study in patients with paroxysmal supraventricular tachycardia

E. H. Christiansen1, L. Frost1, F. Andreasen2, P. Mortensen1, P. E. B. Thomsen1 and A. K. Pedersen1

1Department of Cardiology, Skejby Sygehus, University Hospital Aarhus, Denmark; 2Centre for Clinical Pharmacology, Aarhus University Aarhus, Denmark

Abstract

AIMS: The role of magnesium as an antiarrhythmic drug is yet not conclusive. Therefore, we performed a double-blind, randomized, placebo-controlled dose-response study of cardiac electrophysiological effects of intravenous magnesium.

METHODS AND RESULTS: Thirty-six patients undergoing an electrophysiological evaluation for paroxysmal supraventricular tachycardia were randomized to one of the following dosages of intravenous magnesium (0, 5, 10 or 20 mmol). Conventional electrophysiological variables for sinus node function, atrial, atrioventricular node and ventricular conduction and refractoriness were measured before and after magnesium administration. Prolongation of the atrial–His interval was found at 5 mmol of magnesium compared with placebo and no further prolongation was observed at higher doses (–3±8, 11±9, 7±15, 11±16, for the dosages of 0, 5, 10 and 20 mmol of magnesium, respectively, P< 0·05). Measures of sinus node function, intra-atrial conduction and conduction through the Purkinje system were unaffected by magnesium. Male gender was associated with prolongation in atrial effective refractory period, in contrast to shortening in females: 2±43, 35±44, 36±33, 13±12 ms for males and 3±6, –12±11, –13±12, 0±23 ms for females, respectively (P< 0·001).

CONCLUSION: Atrioventricular node conduction was prolonged by 5 mmol intravenous magnesium and no further prolongation was observed at higher dosages. At dosages of 5 and 10 mmol magnesium the atrial effective refractoriness was prolonged in males and shortened in females.

Key Words: Magnesium, arrhythmia, electrocardiography, atrioventricular node conduction, cardiac refractoriness

Correspondence: Evald Høj Christiansen, MD, PhD, Department of Cardiology, Skejby University Hospital, DK-8200 Aarhus N, Denmark.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 HeartHome page
K. M Ho, D. J Sheridan, and T. Paterson
Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis
Heart, November 1, 2007; 93(11): 1433 - 1440.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
S Miller, E Crystal, M Garfinkle, C Lau, I Lashevsky, and S J Connolly
Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis
Heart, May 1, 2005; 91(5): 618 - 623.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.